Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: Biochemical and functional correlates

Peptides

Volumn 22, Issue 8, 2001, Pages 1229-1234

  Tanganelli, Sergio ^a   Fuxe, Kjell ^b   Antonelli, Tiziana ^a   O'Connor, William Thomas ^c   Ferraro, Luca ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Binding; Cholecystokinin agonists and antagonists; Microdialysis; Motivation and central nervous system disorders; Receptor receptor interactions

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; 4 AMINOBUTYRIC ACID; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ D2 RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; DOPAMINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; BRAIN REGION; CENTRAL NERVOUS SYSTEM DISEASE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; GABAERGIC TRANSMISSION; MICRODIALYSIS; MOTIVATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; CHOLECYSTOKININ; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; HUMANS; KINETICS; MODELS, BIOLOGICAL; NOOTROPIC AGENTS; NUCLEUS ACCUMBENS; PALLADIUM; PROTEIN BINDING; RATS; SINCALIDE; TIME FACTORS;

EID: 0034908119     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00446-6     Document Type: Review

References (34)

1. 3H]N-propylnorapomorphine binding sites
2. The role of CCK caerulein, and CCK antagonists in nociception
3. Cholecystokinins and thier receptors. Functional aspects
4. Amphetamine lowers extracellular GABA concentration in the ventral pallidum
5. Two faces of cholecystokinin: Anxiety and schizophrenia
6. Cholecystokinin-dopamine interactions
7. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviours in rat mesolimbic pathway
8. Biological actions of cholecystokinin
9. 2L receptor cDNAs
10. CCK in anxiety, and cognitive processes
11. Isolation, structure, and biological activity of two cholecystokinin octapeptides from sheep brain
12. Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro
13. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms
14. 2 receptor regulation of rat ventral pallidal GABA levels. A dual probe microdialysis study
15. 2 transmission lines in the central nervous system
16. Functional anatomy of the ventral, limbic system-innervated striatum
17. CCK in animal, and human research on anxiety
18. Cholecystokinin receptors in brain: Effects of obesity, drug treatment and lesions
19. Basal forebrain organization: An anatomical framework for motor aspects of drive and motivation
20. Evidence for coexistence of dopamine and CCK in meso-limbic neurones
21. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing
22. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity
23. Striatal interneurones: Chemical, physiological and morphological characterization
24. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons
25. 2 receptors in rat forebrain sections
26. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms
27. Cholecystokinin in anxiety
28. Two brain cholecystokinin receptors: Implications for behavioural actions
29. CCK-B receptor: Chemistry, molecular biology, biochemistry, and pharmacology
30. Cholecystokinin and panic disorder-three unsettled questions
31. Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins
32. Neurogenesis in the mammalian neostriatum and nucleus accumbens: Parvalbumin-immunoreactive GABAergic interneurons
33. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors
34. New peptide in the vertebrate CNS reacting with antigastrin antibodies